Avtor/Urednik		Fuerst, Jurij; Samaluk, Vita; Peklar, Jure
Naslov		Poraba zdravil za zdravljenje respiratornih bolezni in kašlja v pediatriji
Prevedeni naslov		Drug use for treatment od respiratory illnesses and cough in paediatrics
Tip		članek
Vir		In: Gregorič A, editor. Prepoznava in obravnava duševnih motenj pri otrocih in mladostnikih, dolgotrajni kašelj pri otrocih, obravnava debelosti pri otrocih on mladostnikih na primarni zdravstveni ravni. Zbornik 16. srečanje pediatrov v Mariboru z mednarodno udeležbo in 3. srečanje medicinskih sester; 2006 apr 7-8; Maribor. Maribor: Splošna bolnišnica Maribor,
Leto izdaje		2006
Obseg		str. 151-3
Jezik		slo
Abstrakt		The Slovenian health insurance list of respiratory drugs is up-to-date. In the last 6 years the consumption of combined inhaled glucocorticoids with selective beta2 agonists, leukotriene receptor antagonists and anticholinergic bronchodilators has increased, while the use of inhaled glucocorticoids and selective beta2 agonists has decreased. There are significant regional differences in consumption. Age-related use is linear under the age of 19 years, after which it rises steeply. Prescribing of cough suppressants has significantly declined following the implementation of health insurance prescribing limitations in the year 2000. Expenditure on respiratory drugs has doubled in the last six years. Expenditure on combined inhaled glucocorticoids with selective beta2 agonists constitutes 42% of all respiratory drug expenditure. The prices of daily treatment with different respiratory drugs show great variability between comparable effective drugs.
Deskriptorji		RESPIRATORY TRACT DISEASES DRUG UTILIZATION ANTITUSSIVE AGENTS DRUG COSTS ADMINISTRATION, INHALATION AGE FACTORS